BG103115A - Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety - Google Patents

Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety

Info

Publication number
BG103115A
BG103115A BG103115A BG10311599A BG103115A BG 103115 A BG103115 A BG 103115A BG 103115 A BG103115 A BG 103115A BG 10311599 A BG10311599 A BG 10311599A BG 103115 A BG103115 A BG 103115A
Authority
BG
Bulgaria
Prior art keywords
steroids
strimulators
syptoms
syndrom
neurochemical
Prior art date
Application number
BG103115A
Other languages
Bulgarian (bg)
English (en)
Inventor
Clive Jennings-White
David Berliner
Nathan Adams
Luis Bloch-Monti
Original Assignee
Pherin Pharmaceuticals, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/686,092 external-priority patent/US6057439A/en
Application filed by Pherin Pharmaceuticals, Inc filed Critical Pherin Pharmaceuticals, Inc
Publication of BG103115A publication Critical patent/BG103115A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/002Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BG103115A 1996-07-23 1999-01-25 Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety BG103115A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/686,092 US6057439A (en) 1994-08-04 1996-07-23 Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US72586296A 1996-10-04 1996-10-04
PCT/US1997/013035 WO1998003207A1 (en) 1996-07-23 1997-07-23 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety

Publications (1)

Publication Number Publication Date
BG103115A true BG103115A (en) 1999-09-30

Family

ID=27103741

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103115A BG103115A (en) 1996-07-23 1999-01-25 Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety

Country Status (15)

Country Link
EP (1) EP0914165B1 (de)
JP (1) JP4450435B2 (de)
KR (1) KR20000067970A (de)
CN (1) CN1226837A (de)
AT (1) ATE342721T1 (de)
AU (1) AU726625B2 (de)
BG (1) BG103115A (de)
BR (1) BR9711812A (de)
CA (1) CA2260253A1 (de)
DE (1) DE69736833T2 (de)
ES (1) ES2273374T3 (de)
NO (1) NO990305L (de)
NZ (1) NZ333671A (de)
PL (1) PL331357A1 (de)
WO (1) WO1998003207A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
FR2791572A1 (fr) * 1999-03-31 2000-10-06 Adir Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables
WO2001041732A1 (en) * 1999-12-06 2001-06-14 Gore Stanley L Compositions and methods for intranasal delivery of active agents to the brain
US6555531B1 (en) * 1999-12-30 2003-04-29 Pherin Pharmaceuticals, Inc. Weight promoting composition, method, and product
US8309539B2 (en) 2005-09-09 2012-11-13 Pherin Pharmaceuticals, Inc. Acute treatment of social phobia
CN102056484B (zh) * 2008-04-09 2014-10-29 费林药业公司 用于热潮红的类固醇治疗
JP6283689B2 (ja) * 2012-12-28 2018-02-21 フィーリン・ファーマシューティカルズ・インコーポレイテッドPherin Pharmaceuticals,Inc. うつ病性障害の処置のためのプレグナ‐4‐エン‐20‐イン‐3‐オンの使用
US11419881B2 (en) * 2019-04-15 2022-08-23 Pherin Pharmaceuticals, Inc. Treatment of migraine
WO2021080880A1 (en) * 2019-10-25 2021-04-29 Covey Douglas Nmdar inhibiting agents and gabaar potentiating agents and uses thereof
CN112608358A (zh) * 2020-12-29 2021-04-06 北京大学 一种促进花粉萌发的化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208227A (en) * 1987-08-25 1993-05-04 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
JPH09501408A (ja) * 1993-06-15 1997-02-10 フェリン コーポレイション ヒト視床下部機能における変化の神経化学的イニシエータとしてのエストレンステロイドおよび関連する薬理組成物並びに方法
EP0711169B1 (de) * 1993-06-15 2003-12-10 Pherin Corporation Androstansteroide als neurochemische initiatoren einer veränderung der hypothalamusfunktion beim menschen und verwandte pharmazeutische präparate und verfahren
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
HUT76856A (en) * 1994-09-29 1997-12-29 Pherin Corp Novel estrenes for inducing hypothalamic effects
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function

Also Published As

Publication number Publication date
EP0914165B1 (de) 2006-10-18
AU3963797A (en) 1998-02-10
AU726625B2 (en) 2000-11-16
EP0914165A1 (de) 1999-05-12
CN1226837A (zh) 1999-08-25
CA2260253A1 (en) 1998-01-29
EP0914165A4 (de) 2004-01-21
NZ333671A (en) 2000-07-28
JP4450435B2 (ja) 2010-04-14
ES2273374T3 (es) 2007-05-01
KR20000067970A (ko) 2000-11-25
NO990305L (no) 1999-03-22
DE69736833T2 (de) 2007-05-24
JP2000513000A (ja) 2000-10-03
NO990305D0 (no) 1999-01-22
WO1998003207A1 (en) 1998-01-29
DE69736833D1 (de) 2006-11-30
BR9711812A (pt) 1999-08-24
PL331357A1 (en) 1999-07-05
ATE342721T1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
HK1045812A1 (en) New use for budesonide and formoterol
BG101354A (en) Sterol compositions of sapinofication pulp
DE69432990D1 (de) PROGESTAGEN-FREIE FORMULIERUNGEN VON GnRH UND ESTROGEN ZUR BEHANDLUNG VON BENIGNEN GYNÄKOLOGISCHEN STÖRUNGEN
ATE241337T1 (de) Hautpflegemittel für gealterte haut
BG103115A (en) Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety
IL136972A0 (en) Novel anti-estrogenic steroids and associated pharmaceutical compositions and methods of use
PL324970A1 (en) Method of and composition for treating asthma
DE69329240D1 (de) 17-ether und thioether von 4-aza-steroiden
DE69722223D1 (de) Textilweichspülmittelzusammensetzung und anwendungsmethode für die freisetzung von riechstoffderivaten
CA2069483A1 (en) Steroid sulphatase inhibitors
HUP9801175A3 (en) Topically applied pharmaceutical composition, method of preparing it and its use
DE69706225D1 (de) Verfahren zur Herstellung von Wasserstof und Sauerstoff
GR3036710T3 (en) Monofunctional and/or polyfunctional polylysine conjugates
EP0761239A4 (de) Desodorierendes verfahren, deodorant, verfahren zur deodorantherstellung und desodorierende ausstattung
BG103286A (en) Compositions and methods for ore dressing
BG103170A (en) Polymorphic form ii of finasteride and method for its preparation
ZA96737B (en) Cosmetic compositions for reducing or preventing signs of cullulite
HUP0002716A3 (en) Perfumed one and two phase compositions for reducing body odor and methods of use thereof
EP0987030A4 (de) Desodorant, desodorisiervorrichtung und filter mit diesem desodorant, und verfahren zur desodorisation
DE69722484D1 (de) Präparat für Aerosol-Antitranspirant und Verfahren zur Herstellung
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
BG103060A (en) 19-nor-holan steroids as neurochemical initiators of the change of the operation of the hypothalamus in human organism
CA2232433A1 (fr) Nouvelle composition reductrice et nouveau procede pour la deformation permanente des cheveux
GB9814646D0 (en) Method of reducing or preventing malodour
IL129177A0 (en) Methods and compositions for lipidization of hydrophilic molecules